The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report

Joshua P. Kesterson, Paulette Mhawech-Fauceglia, Shashikant Lele

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Background: The potential role of bevacizumab in the treatment of ovarian granulosa-cell tumors has not been evaluated. Case: An 82 year old woman with refractory ovarian granulosa-cell carcinoma was treated with bevacizumab with symptomatic relief of ascites. Conclusion: Bevacizumab may have a role in the management of malignant ascites in the patient with refractory granulosa-cell carcinoma of the ovary which should be confirmed in a larger series of well selected patients.

Original languageEnglish (US)
Pages (from-to)527-529
Number of pages3
JournalGynecologic Oncology
Volume111
Issue number3
DOIs
StatePublished - Dec 2008

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report'. Together they form a unique fingerprint.

Cite this